Health
Heparin May Reduce SARS-CoV-2 Infection Risk – MD Magazine
New research shows the anticoagulant binds tightly with the coronavirus’ surface spike protein.
An original version of this article was published on sister publication Contagion.US Food and Drug Administration (FDA)-approved anticoagulant heparin may lower the odds of SARS-CoV-2 infection, according to investigators from the Rensselaer Polytechnic Institute (RPI).
SARS-CoV-2 uses its surface spike protein to bind to human cells. Heparin, a blood thinner also available in non-anticoagulant formulations, binds tightly with the coronavirus’ surface spike protein. A team led by Robert Linhard…
-
Noosa News24 hours agoStar Casino walks from Queen’s Wharf sale in Brisbane after $300M Bally’s lifeline
-
Noosa News14 hours ago2025’s Melbourne International Film Festival Is Opening with the Rose Byrne-Starring ‘If I Had Legs I’d Kick You’
-
Business16 hours agoA key reason why many ASX fund managers underperformed last financial year
-
General14 hours agoSuspended Townsville mayor Troy Thompson gets pay rise despite CCC probe